US-UK pharma trade deal paints a costly economic picture for NHS - Pharmaceutical Technology

Financial research published in the BMJ shows the trade deal could end up costing the NHS tens of billions. Financial research published in the BMJ shows the trade deal could end up costing the NHS tens of billions. UK ministers, including science and technology secretary, Liz Kendall, have lauded the deal, which was agreed in late 2025. Credit: Vladimir Sukhachev/Shutterstock.com. The UK-US pharmaceuticals deal could cost the National Health Service (NHS) around £45bn ($60bn) within a decade and divert resources away from essential services, an analysis has suggested. The UK and US governments struck a “landmark” agreement in December 2025,…

Source: Pharmaceutical Technology